BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29316044)

  • 1. Global transcriptome profiling of mild relapsing-remitting versus primary progressive multiple sclerosis.
    Koch MW; Ilnytskyy Y; Golubov A; Metz LM; Yong VW; Kovalchuk O
    Eur J Neurol; 2018 Apr; 25(4):651-658. PubMed ID: 29316044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
    Ratzer R; Søndergaard HB; Christensen JR; Börnsen L; Borup R; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Dec; 19(14):1841-8. PubMed ID: 24085340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
    Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
    Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global map of physical interactions among differentially expressed genes in multiple sclerosis relapses and remissions.
    Tuller T; Atar S; Ruppin E; Gurevich M; Achiron A
    Hum Mol Genet; 2011 Sep; 20(18):3606-19. PubMed ID: 21676896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of MIR21 in CD4+ T cells from patients with relapsing-remitting multiple sclerosis associates with lower miRNA-21 levels and concomitant up-regulation of its target genes.
    Ruhrmann S; Ewing E; Piket E; Kular L; Cetrulo Lorenzi JC; Fernandes SJ; Morikawa H; Aeinehband S; Sayols-Baixeras S; Aslibekyan S; Absher DM; Arnett DK; Tegner J; Gomez-Cabrero D; Piehl F; Jagodic M
    Mult Scler; 2018 Sep; 24(10):1288-1300. PubMed ID: 28766461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.
    Booth DR; Arthur AT; Teutsch SM; Bye C; Rubio J; Armati PJ; Pollard JD; Heard RN; Stewart GJ;
    J Mol Med (Berl); 2005 Oct; 83(10):822-30. PubMed ID: 16075257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of primary progressive multiple sclerosis.
    Cree BA
    Handb Clin Neurol; 2014; 122():211-30. PubMed ID: 24507520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
    Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
    J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort.
    Martinelli-Boneschi F; Esposito F; Scalabrini D; Fenoglio C; Rodegher ME; Brambilla P; Colombo B; Ghezzi A; Capra R; Collimedaglia L; Coniglio G; De Riz M; Serpente M; Cantoni C; Scarpini E; Martinelli V; Galimberti D; Comi G
    Eur J Neurol; 2010 May; 17(5):740-5. PubMed ID: 20067515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of IFN-β inducible gene expression in primary-progressive and relapsing-remitting multiple sclerosis.
    Boppana S; Mindur JE; Balashov KE; Dhib-Jalbut S; Ito K
    J Neuroimmunol; 2013 Dec; 265(1-2):68-74. PubMed ID: 24200257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole transcriptome analysis of multiple Sclerosis patients reveals active inflammatory profile in relapsing patients and downregulation of neurological repair pathways in secondary progressive cases.
    Nali LH; Olival GS; Sousa FTG; de Oliveira ACS; Montenegro H; da Silva IT; Dias-Neto E; Naya H; Spangenberg L; Penalva-de-Oliveira AC; Romano CM
    Mult Scler Relat Disord; 2020 Sep; 44():102243. PubMed ID: 32559700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
    Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
    Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of interleukin-4 receptor alpha chain variants in multiple sclerosis.
    Hackstein H; Bitsch A; Bohnert A; Hofmann H; Weber F; Ohly A; Linington C; Mäurer M; Poser S; Rieckmann P; Bein G
    J Neuroimmunol; 2001 Feb; 113(2):240-8. PubMed ID: 11164908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for association of chromosome 10 open reading frame (C10orf27) gene polymorphisms and multiple sclerosis.
    Goertsches R; Baranzini SE; Morcillo C; Nos C; Camiña M; Oksenberg JR; Montalban X; Comabella M
    Mult Scler; 2008 Apr; 14(3):412-4. PubMed ID: 18208870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA Methylation Profile of CD14+ Monocytes Changes in Primary Progressive Multiple Sclerosis].
    Kiselev IS; Kulakova OG; Baturina OA; Kabilov MR; Boyko AN; Favorova OO
    Mol Biol (Mosk); 2023; 57(5):819-826. PubMed ID: 37752647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors.
    Thewissen K; Nuyts AH; Deckx N; Van Wijmeersch B; Nagels G; D'hooghe M; Willekens B; Cras P; Eijnde BO; Goossens H; Van Tendeloo VF; Stinissen P; Berneman ZN; Hellings N; Cools N
    Mult Scler; 2014 Apr; 20(5):548-57. PubMed ID: 24057429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
    Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered secretory and neuroprotective function of the choroid plexus in progressive multiple sclerosis.
    Rodríguez-Lorenzo S; Ferreira Francisco DM; Vos R; van Het Hof B; Rijnsburger M; Schroten H; Ishikawa H; Beaino W; Bruggmann R; Kooij G; de Vries HE
    Acta Neuropathol Commun; 2020 Mar; 8(1):35. PubMed ID: 32192527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.
    Ramil E; Sánchez AJ; González-Pérez P; Rodríguez-Antigüedad A; Gómez-Lozano N; Ortiz P; Arroyo R; De las Heras V; Vilches C; García-Merino A
    Mult Scler; 2010 Feb; 16(2):139-46. PubMed ID: 20007426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression in familial and nonfamilial MS.
    Koch M; Uyttenboogaart M; Heerings M; Heersema D; Mostert J; De Keyser J
    Mult Scler; 2008 Apr; 14(3):300-6. PubMed ID: 18208881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.